A detailed history of Morgan Stanley transactions in Conmed Corp stock. As of the latest transaction made, Morgan Stanley holds 344,207 shares of CNMD stock, worth $24.9 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
344,207
Previous 288,860 19.16%
Holding current value
$24.9 Million
Previous $20 Million 23.63%
% of portfolio
0.0%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$64.09 - $76.92 $3.55 Million - $4.26 Million
55,347 Added 19.16%
344,207 $24.8 Million
Q2 2024

Oct 17, 2024

SELL
$61.9 - $80.36 $6.41 Million - $8.33 Million
-103,610 Reduced 26.4%
288,860 $20 Million
Q2 2024

Aug 14, 2024

SELL
$61.9 - $80.36 $6.41 Million - $8.33 Million
-103,610 Reduced 26.4%
288,860 $20 Million
Q1 2024

Oct 17, 2024

BUY
$75.36 - $112.51 $7.81 Million - $11.7 Million
103,610 Added 35.87%
392,470 $31.4 Million
Q1 2024

Aug 16, 2024

BUY
$75.36 - $112.51 $2.57 Million - $3.83 Million
34,064 Added 9.5%
392,470 $31.4 Million
Q1 2024

May 15, 2024

BUY
$75.36 - $112.51 $2.57 Million - $3.83 Million
34,064 Added 9.5%
392,470 $31.4 Million
Q4 2023

Aug 16, 2024

BUY
$91.3 - $115.05 $6.35 Million - $8 Million
69,546 Added 24.08%
358,406 $39.2 Million
Q4 2023

Feb 13, 2024

SELL
$91.3 - $115.05 $15.5 Million - $19.6 Million
-170,233 Reduced 32.2%
358,406 $39.2 Million
Q3 2023

Nov 15, 2023

BUY
$97.55 - $135.91 $22.3 Million - $31 Million
228,397 Added 76.07%
528,639 $53.3 Million
Q2 2023

Aug 14, 2023

BUY
$102.55 - $136.38 $5.5 Million - $7.32 Million
53,649 Added 21.76%
300,242 $40.8 Million
Q1 2023

May 15, 2023

SELL
$89.75 - $107.27 $19.7 Million - $23.5 Million
-219,322 Reduced 47.07%
246,593 $25.6 Million
Q4 2022

Feb 14, 2023

BUY
$72.84 - $94.04 $14.8 Million - $19.1 Million
202,820 Added 77.09%
465,915 $41.3 Million
Q3 2022

Nov 14, 2022

BUY
$77.78 - $103.92 $2.69 Million - $3.6 Million
34,599 Added 15.14%
263,095 $21.1 Million
Q2 2022

Oct 27, 2022

BUY
$88.23 - $154.18 $8.98 Million - $15.7 Million
101,764 Added 80.3%
228,496 $21.9 Million
Q2 2022

Aug 15, 2022

BUY
$88.23 - $154.18 $8.98 Million - $15.7 Million
101,764 Added 80.3%
228,496 $21.9 Million
Q1 2022

Oct 27, 2022

SELL
$121.88 - $150.0 $12.4 Million - $15.3 Million
-101,764 Reduced 44.54%
126,732 $18.8 Million
Q1 2022

May 13, 2022

SELL
$121.88 - $150.0 $867,054 - $1.07 Million
-7,114 Reduced 5.32%
126,732 $18.8 Million
Q4 2021

Feb 14, 2022

BUY
$129.86 - $157.03 $951,873 - $1.15 Million
7,330 Added 5.79%
133,846 $19 Million
Q3 2021

Nov 15, 2021

BUY
$122.87 - $139.12 $15.5 Million - $17.6 Million
126,516 New
126,516 $16.6 Million

Others Institutions Holding CNMD

About CONMED Corp


  • Ticker CNMD
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 30,482,400
  • Market Cap $2.2B
  • Description
  • CONMED Corporation, a medical technology company, develops, manufactures, and sells surgical devices and related equipment for surgical procedures worldwide. It offers orthopedic surgery products, including TruShot with Y-Knot All-In-One Soft Tissue Fixation System, Y-knot All-Suture Anchors, and PopLok Knotless Suture Anchors, which provide uni...
More about CNMD
Track This Portfolio

Track Morgan Stanley Portfolio

Follow Morgan Stanley and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.